CTNS and cystinosis: We found that surface binding of GST-RAP was reduced by ~30% (p<0.05) in CTNS KD HK-2 cells (Fig. 3a, b) and by ~60% (p<0.01) in ciPTEC derived from a cystinosis patient (Fig. 3c, d) as compared to control.